ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)Michele Ghielmini, Markus Raderer, Umberto Vitolo et al.|Annals of Oncology|2012Cited by 218
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upHervé Tilly, M. Dreyling, Umberto Vitolo et al.|Annals of Oncology|2012Cited by 172
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Eva Hoster, Sirpa Leppä et al.|The Lancet|2024Cited by 135
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysisMassimo Federico, Bertrand Coiffier, María Dolores Caballero Barrigón et al.|The Lancet Haematology|2018Cited by 116
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Estella Matutes, Alessio Bruscaggin et al.|Blood|2021Cited by 96